Becton, Dickinson and Company (BDX) Wells Fargo 2024 Healthcare Conference
Becton, Dickinson and Company (NYSE:BDX ) Wells Fargo 2024 Healthcare Conference September 4, 2024 8:45 AM ET Company Participants Tom Polen - Chairman, President & CEO Conference Call Participants...
Why Becton Dickinson (BDX) is a Top Momentum Stock for the Long-Term
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Becton, Dickinson And Company: Somewhat Undervalued, A Very Moderate Buy
Becton, Dickinson is overwhelmingly considered undervalued by Wall Street analysts, with an average price target of ~$280 and highs of $312-$330. This is supported by my extensive DCF and comps mod...
Becton Dickinson (BDX) Q3 Earnings Beat Estimates
Becton Dickinson (BDX) came out with quarterly earnings of $3.50 per share, beating the Zacks Consensus Estimate of $3.31 per share. This compares to earnings of $2.96 per share a year ago.
BDX vs. MMSI: Which Stock Should Value Investors Buy Now?
Investors looking for stocks in the Medical - Dental Supplies sector might want to consider either Becton Dickinson (BDX) or Merit Medical (MMSI). But which of these two stocks offers value investo...
BD Statement on Supplier Issue Impacting BD BACTEC™ Blood Culture Vials
Company Committed to Support Global Health and Customers BD Taking all Available Measures to Mitigate Supplier Issue FRANKLIN LAKES, N.J. , July 10, 2024 /PRNewswire/ -- BD (Becton, Dickinson and ...
Three Reasons to Hold BD (BDX) Stock in Your Portfolio Now
BD's (BDX) robust product portfolio raises optimism about the stock.
BD's (BDX) New Research Tool to Aid Single-Cell Analysis
BD (BDX) announces the commercial launch of its new single-cell research tool, BD Rhapsody ATAC-Seq Assay, to help researchers understand DNA regulation.
New BD Research Tool Helps Scientists Study Cells that are Often Key Culprits in the Development of Cancer and Infectious Diseases
BD Rhapsody™ ATAC-Seq Assay Helps Researchers Understand DNA Regulation and Enable Advancements in Precision Medicine FRANKLIN LAKES, N.J. , June 26, 2024 /PRNewswire/ -- BD (Becton, Dickinson and ...
BD Announces Dates for Third Quarter and Fourth Quarter Fiscal 2024 Earnings Webcasts
FRANKLIN LAKES, N.J. , June 20, 2024 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced today that it plans to host webcasts to d...
My Best Dividend Aristocrats For June 2024
The ProShares S&P 500 Dividend Aristocrats ETF hits its first speed bump in April, dropping by 4.69%. Some of this loss has been recovered in May. I present 3 strategies that can theoretically beat...
Levi & Korsinsky, LLP Notifies Shareholders of Becton, Dickinson and Company (BDX) an Upcoming Claims Deadline in a Class Action Settlement
NEW YORK, NY / ACCESSWIRE / May 16, 2024 / Levi & Korsinsky informs shareholders that a settlement has been reached in the pending class action lawsuit against Becton, Dickinson and Company (NYSE:B...
Here's Why Becton Dickinson (BDX) is a Strong Value Stock
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Compared to Estimates, Becton Dickinson (BDX) Q2 Earnings: A Look at Key Metrics
The headline numbers for Becton Dickinson (BDX) give insight into how the company performed in the quarter ended March 2024, but it may be worthwhile to compare some of its key metrics to Wall Stre...
BD (BDX) Q2 Earnings Surpass Estimates, FY24 View Revised
BD's (BDX) overall top line benefits from revenue growth in all segments and both geographic regions in the fiscal second quarter.
Related Companies